
A senior official at Memorial Sloan Kettering Cancer Center has received millions of dollars in payments from companies that are involved in medical research. CHARLES ORNSTEIN and KATIE THOMAS https://ift.tt/2MZdCgq https://ift.tt/2Megl02 The New York Times Health Drugs (Pharmaceuticals), Clinical Trials, Breast Cancer, Ethics and Official Misconduct September 8, 2018 at 12:00AM
Comments
Post a Comment